Main
>
ONCOLOGY (**)
>
Mesothelioma>Pleural>Malignant
>
TREAT.:
>
USA. B. NivoluMAb+IpilimuMAb
>
(*) USA Approval Date: 2020. 10.02
(*) USA Approval Date: 2020. 10.02's products
This section has no products